Soluble CD40 ligand and platelets: Self-perpetuating pathogenic loop in thrombosis and inflammation?

Journal of the American College of Cardiology

Volumn 43, Issue 12, 2004, Pages 2326-2328

  Aukrust, Pal ^a   Damas, Jan Kristian ^a   Solum, Nils Olav ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CD4 ANTIGEN; CD40 ANTIGEN; CD40 LIGAND; CHEMOKINE RECEPTOR; CLOPIDOGREL; GLYCOPROTEIN; TUMOR NECROSIS FACTOR ALPHA;

CELL FUNCTION; CELL SECRETION; CYTOKINE PRODUCTION; HUMAN; IMMUNOREGULATION; INFLAMMATION; MEDIATOR RELEASE; NONHUMAN; NOTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOGENESIS; THROMBOSIS;

EID: 2942519747     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2004.03.023     Document Type: Editorial

References (19)

1. Ruggeri Z.M. Platelets in atherothrombosis. Nat Med. 8:2002;1227-1234
2. Aukrust P., Wæhre T., Damȧs J.K., Gullestad L., Solum N.O. Inflammatory role of platelets in acute coronary syndromes. Heart. 86:2001;605-606
3. Anand S.X., Viles-Gonzalez J.F., Badimon J.J., Cavusoglu E., Marmur J.D. Membrane-associated CD40L and sCD40L in atherothrombotic disease. Thromb Haemost. 90:2003;377-384
4. Aukrust P., Müller F., Ueland T., et al. Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina - possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes. Circulation. 100:1999;614-620
5. Schonbeck U., Varo N., Libby P., Buring J., Ridker P.M. Soluble CD40L and cardiovascular risk in women. Circulation. 104:2001;2266-2268
6. Henn V., Slupsky J.R., Grafe M., et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature. 391:1998;591-594
7. Lutgens E., Gorelik L., Kleutjens K.B., et al. Requirement for CD154 in the progression of atherosclerosis. Nat Med. 5:1999;1313-1316
8. Lutgens E., Cleutjens K.B., Heeneman S., et al. Both early and delayed anti-CD40L antibody treatment induces a stable plaque phenotype. Proc Natl Acad Sci USA. 97:2000;7464-7469
9. Andre P., Srinivasa Prasad K.S., Denis C.V., et al. CD40L stabilizes arterial thrombi by a β3 integrin-dependent mechanism. Nat Med. 8:2002;247-252
10. Srinivasa Prasad K.S., Andre P., He M., et al. Soluble CD40 ligand induces b3 intergrin tyrosine phosphorylation and triggers platelet activation by outside-in signaling. Proc Natl Acad Sci USA. 100:2003;12367-12371
11. Inwald D.P., McDowall A., Peters M.J., Callard R.E., Klein N.J. CD40 is constitutively expressed on platelets and provides a novel mechanism for platelet activation. Circ Res. 92:2003;1041-1048
12. Henn V., Steinbach S., Buchner K., et al. The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40. Blood. 98:2001;1047-1054
13. Furman MI, Krueger LA, Linden MD, Barnard MR, Frelinger AL III, Michelson AD. Release of soluble CD40L from platelets is regulated by glycoprotein IIb/IIIa and actin polymerization. J Am Coll Cardiol 2004;43:2319-25.
14. Nannizzi-Alaimo L., Alves V.L., Phillips D.R. Inhibitory effects of glycoprotein IIb/IIIa antagonists and aspirin on the release of soluble CD40 ligand during platelet stimulation. Circulation. 107:2003;1123-1128
15. Topol E.J., Ferguson J.J., Weisman H.F., et al. Long-term protection from myocardial ischemic events in a randomized trial of brief integrin beta3 blockade with percutaneous coronary intervention Epic investigator group. JAMA. 278:1997;479-484
16. May A.E., Kalsch T., Massberg S., et al. Engagement of glycoprotein IIb/IIIa (α(IIb)β3) on platelets upregulates CD40L and triggers CD40L-dependent matrix degradation by endothelial cells. Circulation. 106:2002;2111-2117
17. Bhatt D.L., Topol E.J. Current role of platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes. JAMA. 284:2000;1549-1558
18. Hermann A., Rauch B.H., Braun M., et al. Platelet CD40 ligand (CD40L)-subcellular localization, regulation of expression, and inhibition by clopidogrel. Platelets. 12:2001;74-82
19. Kawai T, Andrews D, Colvin RB, et al. Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand. Nat Med 2000;6:114.